Corvus Pharmaceuticals Provides Business Update and Reports
Soquelitinib Phase 1 Randomized Trial in Atopic Dermatitis Enrolling at Multiple Centers; Potential for Early Data Before Year-End 2024 Soquelitinib...
Source: globenewswire.com
Leiv Lea News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Leiv Lea. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Leiv Lea Today - Breaking & Trending Today
Corvus Pharmaceuticals Announces Pricing of $30.6 Million Registered Direct Offering
BURLINGAME, Calif., May 02, 2024 -- Corvus Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, today announced that it has entered into a securities purchase agreement with new...
Source: marketscreener.com
Corvus Pharmaceuticals to Provide Business Update and First Quarter 2024 Financial Results on May 6, 2024
BURLINGAME, Calif., May 02, 2024 -- Corvus Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, today announced that the company will host a conference call and webcast on May 6,...
Source: marketscreener.com
Corvus Pharmaceuticals Announces Initiation of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis
Atopic dermatitis is the first immune disease indication being studied in the clinic for soquelitinib, the Company’s selective ITK inhibitorCorvus...
Source: businessinsider.com
Corvus Pharmaceuticals Appoints Jeffrey Arcara as Chief Business Officer
BURLINGAME, Calif., Feb. 06, 2024 -- Corvus Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, today announced the appointment of Jeffrey Arcara as Chief Business Officer. Mr....
Source: marketscreener.com